APA (7th ed.) Citation

Arockiaraj, N., Gupta, R., Ahmad, R., Halder, S., & Bhatia, M. S. (2024). Sertraline with desvenlafaxine and sertraline with mirtazapine as treatment initiation in MDD patients with moderate to severe depression and effect on inflammatory markers. International Journal of Psychiatry in Clinical Practice, 28(1), 9. https://doi.org/10.1080/13651501.2023.2287754

Chicago Style (17th ed.) Citation

Arockiaraj, Norman, Rachna Gupta, Rafat Ahmad, Sumita Halder, and M. S. Bhatia. "Sertraline with Desvenlafaxine and Sertraline with Mirtazapine as Treatment Initiation in MDD Patients with Moderate to Severe Depression and Effect on Inflammatory Markers." International Journal of Psychiatry in Clinical Practice 28, no. 1 (2024): 9. https://doi.org/10.1080/13651501.2023.2287754.

MLA (9th ed.) Citation

Arockiaraj, Norman, et al. "Sertraline with Desvenlafaxine and Sertraline with Mirtazapine as Treatment Initiation in MDD Patients with Moderate to Severe Depression and Effect on Inflammatory Markers." International Journal of Psychiatry in Clinical Practice, vol. 28, no. 1, 2024, p. 9, https://doi.org/10.1080/13651501.2023.2287754.